IKZF1 Δ4–7 is independently adversely prognostic, by itself or in combination with IKZF1plus and confers the poorest outcome in patients with BCR::ABL1 and BCR::ABL1-like ALL. This evidence concerns the gene BCR and acute lymphoblastic leukemia.